Volume Control and Left Ventricular Hypertrophy in Patients with End-Stage Renal Disease

Foley R.N. , Parfrey P.S. , Sarnak M.J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(suppl 12): S16–23.

Silberberg J. , Barre P.E. , Prichard S.S. , Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286–90.

Rostand R.G. , Kirk K.A. , Rutsky E.A. Dialysis ischemic heart disease: Insights from coronary angiography. Kidney Int 1984; 25: 653–9.

London G.M. , Fabiani F. , Marchais S.J. , de Vernejoul M-Ch , Guérin A P. , Safar M.E. , Metivier F. , Llach F. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973–80.

Parfrey P. , Foley R. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606–15.

De Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421–7.

Cruz J.M. , Piera L. , Bragg-Gresham J.L. , Feldman H. , Port F.K. Resultados del estudio Internacional de hemodiálisis DOPPS en Europa y España. Nefrologia 2003; 23: 437–43.

Horl M.P. , Horl W.H. Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227–44.

Foley R.N. , Parfrey P.S. , Harnet J.D. , Kent G.M. , Murray D.C. , Barre P.E. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379–85.

Cannella G. , Paoletti E. , Delfino R. , Peloso G. , Molinari S. , Traverso G.B. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881–6.

Foley R.N. , Parfrey P.S. , Harnet J.D. , Kent G.M. , Martin C.J. , Murray D.C. , Barre P.E. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186–92.

Roger S.D. , McMahon L.P. , Clarkson A. , Disney A. , Harris D. , Hawley C. , Healy H. , Kerr P. , Lynn K. , Parnham A. , Pascoe R. , Voss D. , Walker R. , Levin A. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. J Am Soc Nephrol 2004; 15: 148–56.

Rahman M. , Fu P. , Sehgal A.R. , Smith M.C. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257–65.

Locatelli F. , Colzani S. , D'Amico M. , Manzoni C. , Di Filippo S. Dry weight and sodium balance. Semin Nephrol 2001; 21: 291–7.

Katzarski K.S. , Charra B. , Luik A.J. , Nisell J. , Divino Filho J.C. , Leypoldt J.K. , Leunissen K.M. , Laurent G. , Bergstrom J. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369–75.

Fagugli R.M. , Pasini P. , Quintaliani G. , Pasticci F. , Ciao G. , Cicconi G. , Ricciardi D. , Santirosi P.V. , Buoncristiani E. , Timio F. , Valente F. , Buoncristiani U. Association between extracellular water, left ventricular mass and hypertension in hemodialysis patients. Nephrol Dial Transplant 2003; 18: 2332–8.

Ozkahaya M. , Toz H. , Ozerkan F. , Duman S. , Ok E. , Basci A. , Dorhout Mees E.J. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655–60.

Leenen F.H. , Smith D.L. , Khanna R. , Oreopoulos D.G. Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis. Am Heart J 1985; 110: 102–6.

Williams A.W. , Chebrolu S.B. , Ing T.S. , Ting G. , Blagg C.R. , Twardowski Z.J. , Woredekal Y. , Delano B. , Gandhi V.C. , Kjellstrand C.M. , Daily Hemodialysis Study Group. Early clinical, quality-of-life, and biochemical changes of “daily hemodialysis” (6 dialyses per week). Am J Kidney Dis 2004; 43: 90–102.

Woods J.D. , Port F.K. , Orzol S. , Buoncristiani U. , Young E. , Wolfe R.A. , Held P.J. Clinical and biochemical correlates of starting “daily” hemodialysis. Kidney Int 1999; 55: 2467–76.

Fagugli R.M. , Reboldi G. , Quintaliani G. Short daily haemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive haemodialysis patients. Am J Kidney Dis 2001; 38: 371–6.

Maduell F. , Navarro V. , Torregrosa E. , Rius A. , Dicenta F. , Cruz M.C. , Ferrero J.A. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration Kidney Int 2003; 64: 305–13.

Chan C.T. , Floras J.S. , Miller J.A. , Richardson R.M. , Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235–9.

Coomer R.W. , Schulman G. , Breyer J.A. , Shyr Y. Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure. Am J Kidney Dis 1997; 29: 678–84.

Ifudu O. , Dawood M. , Homel P. , Friedman E.A. Excess interdialytic weight gain provokes antihypertensive drug therapy in patients on maintenance hemodialysis. Dial Transplant 1997; 26: 541–59.

Rocco M.V. , Yan G. , Heyka R.J. Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO Study. Am J Nephrol 2001; 21: 280–8.

Leypoldt J.K. , Cheung A.K. , Delmez J.A. , Gassman J.J. , Levin N.W. , Breyer Lewis J.A. , Lewis J.L. , Rocco M.V. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 2000; 61: 266–75.

Maduell F. , Navarro V. Assessment of salt intake in hemodialysis. Nefrologia 2001; 21: 71–7.

Shaldon S. Dietary salt restriction and drug free treatment of hypertension in ESRD patients: A therapeutic tragedy. Nephrol Dial Transplant 2002; 17: 1163–5.

Krautzig S. , Janssen U. , Koch K.M. , Granolleras C. , Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552–3.